SBM: the sterilization and freeze-drying expert

Did you know that every second single-use contact lens is sterilized with an autoclave from Schoeller Bleckmann Medizintechnik (SBM)? With countless projects around the world, over 50 years of experience and more than 15 years within the Syntegon group, SBM is the ideal partner when it comes to pharmaceutical sterilization and freeze-drying processes. The vast portfolio includes customer-specific solutions for the terminal sterilization of medical products and equipment, as well as freeze dryers with loading and unloading systems.

Sterilizing pharmaceutical products and equipment

Reproducible terminal sterilization of medical products and equipment is at the core of SBM’s portfolio. SBM offers all the industry’s most common and preferred methods. From vacuum-steam to steam/air mixture and hot water shower processes, the versatile autoclaves ensure an effective treatment of porous loads and liquids in open, semi-sealed, or closed containers. Combined systems even incorporate multiple processes within a single sterilizer, offering much greater flexibility in terminal sterilization while optimizing energy requirements and ensuring maximum safety throughout the process.

Freeze drying for temperature-sensitive products

When it comes to freeze-drying, the highly scalable SBM system ensures the lyophilization of thermolabile products, such as oncological medicines, vaccines, or antibodies. The modular concept perfectly adapts to the respective working environment and can be fully integrated into an entire range of GMP-compliant machines. Moreover, the patented loading/unloading system provides safe and efficient processes while saving a considerable amount of space.

Go to article: Home | CoverGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: ControlantGo to article: SyntegonGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: CfPIEGo to article: In DepthGo to article: Dawn of a new indication: How to study drugs for aging Go to article: Cleanroom tech tackles environmental impact of consumables Go to article: Tapping into digital therapeutics to improve neurological outcomes Go to article: CMO Moves: Regulatory catalysts for drug manufacturing – March Go to article: Ethics of ultra-rare disease drug development and expanded accessGo to article: APAC early-stage innovators raise one-third less VC funds than US players Go to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: Bio Image Systems Inc.Go to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: the transformative power of cloud Go to article: An introduction to cloud computingGo to article: A history of cloud computingGo to article: The impact of cloud computing on the pharmaceutical industry Go to article: Applications of cloud computing in the pharmaceutical industry Go to article: Latest news: cloud computing in pharma Go to article: Q&A with GlobalData thematic analystGo to article: Is RFID the future of smart labelling?Go to article: Cloud robotics labs are accelerating drug discovery and development Go to article: Leading pharma companies in the cloud computing theme Go to article: Deal activity related to cloud in the pharmaceutical industry since 2020 Go to article: Cloud hiring trends in the global pharmaceutical industry since 2020 Go to article: Cloud patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of cloud in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Pharma Sponsored SupplementsGo to article: HOF SonderanlagenbauGo to article: Thermo Fisher ScientificGo to article: ListingsGo to article: EventsGo to article: RankingsGo to article: Buyer's GuidesGo to article: Next issue